SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/63491"
 

Search: id:"swepub:oai:gup.ub.gu.se/63491" > Survival of patient...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Gustafson, T.Umeå universitet,Institutionen för folkhälsa och klinisk medicin (author)

Survival of patients with kyphoscoliosis receiving mechanical ventilation or oxygen at home

  • Article/chapterEnglish2006

Publisher, publication year, extent ...

  • Elsevier BV,2006

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/63491
  • https://gup.ub.gu.se/publication/63491URI
  • https://lup.lub.lu.se/record/681859URI
  • https://doi.org/10.1378/chest.130.6.1828DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-14568URI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • BACKGROUND: Home mechanical ventilation (HMV) and long-term oxygen therapy (LTOT) are the two treatment alternatives when treating respiratory insufficiency in patients with kyphoscoliosis. We aimed to study the effect on survival with regard to HMV or LTOT alone in patients with respiratory insufficiency due to kyphoscoliosis. METHODS: Swedish patients with nonparalytic kyphoscoliosis (ie, scoliosis not related to neuromuscular disorders) who started LTOT or HMV between 1996 and 2004 were followed up prospectively until February 14, 2006, with death as the primary outcome. Treatment modality, arterial blood gas levels, the presence of concomitant respiratory diseases, and age were recorded at the onset of treatment. No patient was lost to follow-up. RESULTS: One hundred patients received HMV, and 144 patients received oxygen therapy alone. Patients treated with HMV experienced better survival, even when adjusting for age, gender, concomitant respiratory diseases, and blood gas levels, with a hazard ratio of 0.30 (95% confidence interval, 0.18 to 0.51). CONCLUSION: The survival of patients with kyphoscoliosis receiving HMV was better than that of patients treated with LTOT alone. We suggest HMV and not oxygen therapy alone as the primary therapy for patients with respiratory failure due to kyphoscoliosis, regardless of gender, age, and the occurrence of concomitant respiratory diseases.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Franklin, KarlUmeå universitet,Institutionen för folkhälsa och klinisk medicin(Swepub:umu)kafr0021 (author)
  • Midgren, B. (author)
  • Pehrsson, KerstinLund University,Lunds universitet,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för invärtesmedicin,Institute of Medicine, Department of Internal Medicine,Lungmedicin, allergologi och palliativ medicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Respiratory Medicine, Allergology, and Palliative Medicine,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)lung-kpe (author)
  • Ranstam, J. (author)
  • Ström, K. (author)
  • Umeå universitetInstitutionen för folkhälsa och klinisk medicin (creator_code:org_t)

Related titles

  • In:Chest: Elsevier BV130:6, s. 1828-330012-36921931-3543

Internet link

Find in a library

  • Chest (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view